SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005286-24-000112
Filing Date
2024-08-09
Accepted
2024-08-09 17:15:31
Documents
64
Period of Report
2024-02-25

Document Format Files

Seq Description Document Type Size
1 10-Q lfcr-20240225.htm   iXBRL 10-Q 1257765
2 EX-31.1 lfcr-20240225xexx311.htm EX-31.1 11744
3 EX-31.2 lfcr-20240225xexx312.htm EX-31.2 12233
4 EX-32.1 lfcr-20240225xexx321.htm EX-32.1 5716
5 EX-32.2 lfcr-20240225xexx322.htm EX-32.2 5827
  Complete submission text file 0001005286-24-000112.txt   6946680

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfcr-20240225.xsd EX-101.SCH 36548
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfcr-20240225_cal.xml EX-101.CAL 81989
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfcr-20240225_def.xml EX-101.DEF 303250
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfcr-20240225_lab.xml EX-101.LAB 642841
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfcr-20240225_pre.xml EX-101.PRE 460322
67 EXTRACTED XBRL INSTANCE DOCUMENT lfcr-20240225_htm.xml XML 863703
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0526
Type: 10-Q | Act: 34 | File No.: 000-27446 | Film No.: 241193990
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)